Fexinidazole

( DrugBank: Fexinidazole / KEGG DRUG: Fexinidazole )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	9

65. 原発性免疫不全症候群

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 9 of 9 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03974178 (ClinicalTrials.gov)	September 29, 2019	23/5/2019	Efficacy and Safety of Fexinidazolein Patients With Human African Trypanosomiasis (HAT) Due to Trypa ...	Efficacy and Safety of Fexinidazolein Patients With Human African Trypanosomiasis (HAT) Due to Trypa ...	Trypanosoma Brucei Rhodesiense; Infection	Drug: Fexinidazole	Drugs for Neglected Diseases	European and Developing Countries Clinical Trials Partnership (EDCTP)	Completed	6 Years	N/A	All	45	Phase 2/Phase 3	Malawi;Uganda
2	NCT03025789 (ClinicalTrials.gov)	November 17, 2016	11/11/2016	Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage	An Open-label Study Assessing Effectiveness, Safety and Compliance With Fexinidazolein Patients With ...	Trypanosomiasis, African;Sleeping Sickness;Trypanosomiasis; Gambian	Drug: Fexinidazole	Drugs for Neglected Diseases	Sanofi	Completed	6 Years	N/A	All	174	Phase 3	Congo, The Democratic Republic of the;Guinea
3	NCT02571062 (ClinicalTrials.gov)	March 2015	24/6/2015	Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation	A Bioequivalence Study of the Reference Clinical FexinidazoleTablet vs Proposed Market Formulation i ...	Trypanosomiasis, African	Drug: Fexinidazole	Drugs for Neglected Diseases	NULL	Completed	18 Years	45 Years	Male	30	Phase 1	France
4	NCT02498782 (ClinicalTrials.gov)	July 2014	20/8/2014	Study to Evaluate FexinidazoleDosing Regimens for the Treatment of Adult Patients With Chagas Diseas ...	Phase 2, Randomized, Multicenter, Placebo-controlled, Safety and Efficacy Study to Evaluate Six Oral ...	Chagas Disease;Trypanosomiasis, South American;South American Trypanosomiasis;Disease, Chagas	Drug: Fexinidazole;Drug: Placebo	Drugs for Neglected Diseases	NULL	Recruiting	18 Years	50 Years	Both	140	Phase 2	Bolivia
5	NCT02184689 (ClinicalTrials.gov)	May 3, 2014	19/6/2014	Efficacy and Safety of Fexinidazolein Children at Least 6 Years Old and Weighing Over 20 kg With Hum ...	Efficacy and Safety of Fexinidazolein Children at Least 6 Years Old and Weighing Over 20 kg With Hum ...	Human African Trypanosomiasis (HAT)	Drug: fexinidazole	Drugs for Neglected Diseases	NULL	Completed	6 Years	14 Years	All	125	Phase 2/Phase 3	Congo, The Democratic Republic of the
6	NCT02169557 (ClinicalTrials.gov)	April 30, 2014	15/5/2014	Efficacy and Safety of Fexinidazolein Patients With Stage 1 or Early Stage 2 Human African Trypanoso ...	Efficacy and Safety of Fexinidazolein Patients With Stage 1 or Early Stage 2 Human African Trypanoso ...	Human African Trypanosomiasis (HAT)	Drug: Fexinidazole	Drugs for Neglected Diseases	NULL	Completed	15 Years	N/A	All	230	Phase 2/Phase 3	Congo, The Democratic Republic of the
7	NCT01685827 (ClinicalTrials.gov)	October 2012	12/9/2012	Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2	Efficacy and Safety of FexinidazoleCompared to Nifurtimox-Eflornithine Combination Therapy (NECT) in ...	Human African Trypanosomiasis (HAT);Sleeping Sickness	Drug: Fexinidazole;Drug: Nifurtimox;Drug: Eflornithine	Drugs for Neglected Diseases	NULL	Completed	15 Years	N/A	All	394	Phase 2/Phase 3	Central African Republic;Congo, The Democratic Republic of the;Congo
8	NCT01483170 (ClinicalTrials.gov)	September 2011	29/11/2011	Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole(Drug Candida ...	Double-blind, Placebo Controlled, Randomized Multiple Ascending Dose Study in Fed Conditions for Ten ...	Trypanosomiasis, African	Drug: Tablets Fexinidazole;Drug: Placebo	Drugs for Neglected Diseases	NULL	Terminated	18 Years	45 Years	Male	30	Phase 1	France
9	NCT00982904 (ClinicalTrials.gov)	September 2009	22/9/2009	Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidaz ...	Randomized, Double-blind, Placebo-controlled Study of the Tolerability, and Pharmacokinetics of Fexi ...	Human African Trypanosomiasis	Drug: Fexinidazole/Placebo	Drugs for Neglected Diseases	Sanofi	Completed	18 Years	45 Years	Male	108	Phase 1	France

First Previous1Next Last